vs
Side-by-side financial comparison of Phathom Pharmaceuticals, Inc. (PHAT) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $35.3M, roughly 1.6× UNITY BANCORP INC). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 24.2%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-167.0M).
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
PHAT vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.6M | $35.3M |
| Net Profit | — | $15.5M |
| Gross Margin | 86.7% | — |
| Operating Margin | — | 55.8% |
| Net Margin | — | 43.9% |
| Revenue YoY | 94.1% | 24.2% |
| Net Profit YoY | 71.6% | 34.5% |
| EPS (diluted) | — | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.6M | $35.3M | ||
| Q3 25 | $49.5M | $32.8M | ||
| Q2 25 | $39.5M | $34.4M | ||
| Q1 25 | $28.5M | $29.4M | ||
| Q4 24 | $29.7M | $28.4M | ||
| Q3 24 | $16.4M | $27.7M | ||
| Q2 24 | $7.3M | $25.5M | ||
| Q1 24 | — | $25.6M |
| Q4 25 | — | $15.5M | ||
| Q3 25 | $-30.0M | $14.4M | ||
| Q2 25 | $-75.8M | $16.5M | ||
| Q1 25 | $-94.3M | $11.6M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-85.6M | $10.9M | ||
| Q2 24 | $-91.4M | $9.5M | ||
| Q1 24 | — | $9.6M |
| Q4 25 | 86.7% | — | ||
| Q3 25 | 87.5% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 86.9% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 85.6% | — | ||
| Q2 24 | 81.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 55.8% | ||
| Q3 25 | -30.8% | 57.5% | ||
| Q2 25 | -151.7% | 62.6% | ||
| Q1 25 | -276.5% | 52.6% | ||
| Q4 24 | — | 51.0% | ||
| Q3 24 | -433.0% | 52.7% | ||
| Q2 24 | -1055.4% | 49.3% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | — | 43.9% | ||
| Q3 25 | -60.5% | 43.8% | ||
| Q2 25 | -191.9% | 48.0% | ||
| Q1 25 | -330.7% | 39.5% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -523.3% | 39.4% | ||
| Q2 24 | -1248.6% | 37.1% | ||
| Q1 24 | — | 37.5% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | $-0.41 | $1.41 | ||
| Q2 25 | $-1.05 | $1.61 | ||
| Q1 25 | $-1.31 | $1.13 | ||
| Q4 24 | — | $1.13 | ||
| Q3 24 | $-1.32 | $1.07 | ||
| Q2 24 | $-1.56 | $0.92 | ||
| Q1 24 | — | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $130.0M | — |
| Total DebtLower is stronger | $209.1M | — |
| Stockholders' EquityBook value | $-438.2M | $345.6M |
| Total Assets | $259.1M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.0M | — | ||
| Q3 25 | $135.2M | — | ||
| Q2 25 | $149.6M | — | ||
| Q1 25 | $212.3M | — | ||
| Q4 24 | $297.3M | — | ||
| Q3 24 | $334.7M | — | ||
| Q2 24 | $276.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | $209.1M | — | ||
| Q3 25 | $207.1M | — | ||
| Q2 25 | $205.1M | — | ||
| Q1 25 | $203.2M | — | ||
| Q4 24 | $201.4M | $230.8M | ||
| Q3 24 | $175.7M | — | ||
| Q2 24 | $174.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $-438.2M | $345.6M | ||
| Q3 25 | $-422.5M | $334.0M | ||
| Q2 25 | $-405.8M | $319.8M | ||
| Q1 25 | $-338.4M | $306.1M | ||
| Q4 24 | $-253.6M | $295.6M | ||
| Q3 24 | $-187.1M | $284.3M | ||
| Q2 24 | $-233.8M | $273.4M | ||
| Q1 24 | — | $266.8M |
| Q4 25 | $259.1M | $3.0B | ||
| Q3 25 | $240.3M | $2.9B | ||
| Q2 25 | $250.2M | $2.9B | ||
| Q1 25 | $294.2M | $2.8B | ||
| Q4 24 | $378.3M | $2.7B | ||
| Q3 24 | $387.0M | $2.6B | ||
| Q2 24 | $319.4M | $2.6B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.8M | $44.9M |
| Free Cash FlowOCF − Capex | $-167.0M | $44.3M |
| FCF MarginFCF / Revenue | -290.0% | 125.7% |
| Capex IntensityCapex / Revenue | 0.4% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-328.9M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.8M | $44.9M | ||
| Q3 25 | $-14.1M | $45.5M | ||
| Q2 25 | $-62.7M | $-25.3M | ||
| Q1 25 | $-84.9M | $17.9M | ||
| Q4 24 | $-266.8M | $48.0M | ||
| Q3 24 | $-63.6M | $17.7M | ||
| Q2 24 | $-70.7M | $-8.4M | ||
| Q1 24 | — | $15.8M |
| Q4 25 | $-167.0M | $44.3M | ||
| Q3 25 | $-14.1M | $45.3M | ||
| Q2 25 | $-62.8M | $-25.5M | ||
| Q1 25 | $-84.9M | $17.6M | ||
| Q4 24 | $-266.9M | $47.3M | ||
| Q3 24 | $-63.6M | $17.5M | ||
| Q2 24 | $-70.8M | $-8.6M | ||
| Q1 24 | — | $15.7M |
| Q4 25 | -290.0% | 125.7% | ||
| Q3 25 | -28.6% | 138.1% | ||
| Q2 25 | -159.0% | -74.2% | ||
| Q1 25 | -297.9% | 59.9% | ||
| Q4 24 | -899.8% | 166.5% | ||
| Q3 24 | -389.0% | 63.3% | ||
| Q2 24 | -966.2% | -33.7% | ||
| Q1 24 | — | 61.4% |
| Q4 25 | 0.4% | 1.6% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
